Psychedelicnewsbreaks Nrx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files ANDA For Preservative-Free IV Ketamine, Targets Expanding $750M Market April 24, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by menafn. Read more Source: https://menafn.com/1111026575/Psychedelicnewsbreaks-Nrx-Pharmaceuticals-Inc-NASDAQ-NRXP-Files-ANDA-For-Preservative-Free-IV-Ketamine-Targets-Expanding-750M-Market
